Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes

Allogeneic hematopoietic cell transplantation (HCT) benefits children with Hurler syndrome (MPS-IH). However, survivors remain burdened by substantial MPS-IH related residual disease. We studied the feasibility, safety and biochemical impact of augmentative recombinant intravenous enzyme replacement...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Troy C., Miller, Weston P., Liao, Ai Yin, Tolar, Jakub, Shanley, Ryan, Pasquali, Marzia, Sando, Nicole, Bigger, Brian W., Polgreen, Lynda E., Orchard, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773848/
https://www.ncbi.nlm.nih.gov/pubmed/31575939
http://dx.doi.org/10.1038/s41598-019-50595-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773848/
https://www.ncbi.nlm.nih.gov/pubmed/31575939
http://dx.doi.org/10.1038/s41598-019-50595-1

Ejemplares similares